Skip to content

Deferred Taxes at other companies

Amgen logo
AmgenAMGN
-$176M+29.6%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$3M-61.9%
Opko Health logo
Opko HealthOPK
-$7.89M-6.3%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$218K+87.9%
TG Therapeutics logo
TG TherapeuticsTGTX
$3.86M
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
-$61.1M-346%

Segments

By segment

See full
Single reportable segment$3M

Other financials

Income statement

See full
Revenue$58.8M+10.3%
Gross profit$54.2M+10.8%
Operating income$11.9M-7.0%
Net income$8.7M-24.4%
EPS (diluted)$0.44-30.2%

Balance sheet

See full
Cash & equivalents$24.5M-46.6%
Total debt$68.4M+5,079%
Total equity$399.9M+2,054%
Total assets$504.6M+187%

Cash flow

See full
Operating cash flow$2.7M+405%
CapEx$73.0K
Free cash flow-$22.0M

Valuation

See full
Market cap$684.39M+102%
Enterprise value$728.29M+148%
P/E1.9×-7.2×
P/S2.3×+0.6×

Profitability

See full
Gross margin93.4%+3.7pp
Operating margin41.6%+19.9pp
Net margin121.5%+103pp
FCF margin-61.7%

Returns & leverage

See full
Return on equity174.1%
Debt / equity0.2×+0.1×
Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxesAndTaxCredits.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rigel Pharmaceuticals's deferred taxes?
Rigel Pharmaceuticals (RIGL) reported deferred taxes of $2.57M in Q1 2026.
What does deferred taxes mean?
Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.